SCHEMBL7325281

SCHEMBL7325281

O=C(Nc1cccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)c1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 7/20 0.55
SMN1; SMN2 Q16637 5/20 0.55
PPARG P37231 3/20 0.55
MAPK1 P28482 3/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
CYP3A4 P08684 2/20 0.55
LMNA P02545 1/20 0.55
TP53 P04637 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
MAPT P10636 1/20 0.55
CYP2C9 P11712 1/20 0.55
PKM P14618 1/20 0.55
TSHR P16473 1/20 0.55
NFKB1 P19838 1/20 0.55
CYP2C19 P33261 1/20 0.55
THPO P40225 1/20 0.55
MTOR P42345 1/20 0.55
PMP22 Q01453 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7316051 0.82 ORAI1 (0.61) SMN1; SMN2MEN1KMT2ALMNATP53
SCHEMBL7327295 0.82 ORAI1 (0.54) SMN1; SMN2MEN1KMT2ATP53MAPT
SCHEMBL3279081 0.78 P2RX1 (0.60) MEN1KMT2AORAI1TRPC1TRPC3
SCHEMBL18146433 0.78 RORC (0.70) RORCSMN1; SMN2PPARGMAPK1MEN1
SCHEMBL3277751 0.78 PTGS1 (0.49) SMN1; SMN2MEN1KMT2ACYP3A4CYP1A2
SCHEMBL7314688 0.77 TP53 (0.56) SMN1; SMN2MEN1KMT2ALMNATP53
SCHEMBL7130551 0.76 RORC (0.82) RORCSMN1; SMN2PPARGMAPK1MEN1
SCHEMBL7316872 0.76 ORAI1 (0.63) SMN1; SMN2MEN1KMT2ALMNATP53
SCHEMBL7322486 0.76 ORAI1 (0.58) SMN1; SMN2LMNATP53MAPTORAI1
SCHEMBL7320744 0.76 ORAI1 (0.74) MEN1KMT2ALMNATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US claimed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP claimed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO claimed
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP disclosed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 RORC 64/4885SMN1; SMN2 4665/4885PPARG 2890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.